Skip to content

ADAPT

Anxiety: Daily Assessment and Progress in Treatment - ADAPT

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON61130
Enrollment
10
Registered
2026-02-04
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety disorder, panic disorder, agoraphobia, social anxiety disorder, generalized anxiety disorder, obsessive compulsive disorder Anxiety

Interventions

None listed

Sponsors

Pro Persona
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Diagnosed with an anxiety (i.e. panic disorder, agoraphobia, social anxiety disorder, generalized anxiety disorder) or obsessive-compuslive disorder according to DSM-5 criteria18 years and olderBeing able to read and write in Dutch language

Exclusion criteria

Exclusion criteria: Acute psychotic disorder Alcohol abuse or dependence

Design outcomes

Primary

MeasureTime frame
The ESM measurements consist of the same fifteen questions each day, including anxiety symptoms, depressive symptoms, impact of the symptoms, rumination, avoidance, perceived control, self-efficacy expectations, sleep, and personalized treatment goals.

Secondary

MeasureTime frame
Secondary parameters include qualitative experiences and interpretations of participants using semi-structured interviews.

Countries

Netherlands

Contacts

Public ContactÖ Baturlar

Pro Persona

o.baturlar@propersona.nl0641759558

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jun 11, 2026